Minding the body: Psychotherapy and cancer survival
Abstract
Objectives: This article reviews evidence regarding effects of psychotherapy on overall cancer survival time. Special emphasis is given to research on adverse effects of depression on cancer survival, breast cancer, and mediating psychophysiological pathways linking psychosocial support to longer survival. Design: It reviews all published clinical trials addressing effects of psychotherapy on cancer survival, emphasizing depression, breast cancer, and psychophysiological evidence linking stress, depression, and support to cancer survival. Methods: Systematic literature review and synthesis. Results: Eight of 15 published trials indicate that psychotherapy enhances cancer survival time. No studies show an adverse effect of psychotherapy on cancer survival. Potential psychophysiological mechanisms linking stress to shorter survival include dysregulation of diurnal cortisol, increased pro‐inflammatory cytokines, reduced natural killer cell activity, shorter telomeres and lower telomerase activity, glucocorticoid‐mediated suppression of p53 and B r CA 1 gene expression, and sympathetic nervous system activation of vascular endothelial growth factor. Conclusions: Stress and support affect the course of cancer progression. Statement of contribution: What is known? Stress and support have been thought to be related to cancer risk and progression, but evidence has been mixed. Depression is a natural co‐morbid condition with cancer. It has not been clear how stress and support could physiologically affect the rate of cancer progression. Immune function was not thought to have much relevance to cancer progression. Few other physiological mechanisms linking stress to cancer progression were known. What does this paper add? There is evidence from 15 RCT s indicating that effective psychosocial support improves quantity as well as quality of life with cancer. There is evidence that chronic depression predicts poorer prognosis with cancer. Dysregulated circadian cortisol patterns predict more rapid cancer progression. Inflammatory processes affect cancer growth and progression. Sympathetic nervous system activity, telomere length, telomerase activity, and oncogene expression are affected by stress and can affect cancer growth.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Therapies such as cognitive behavioral therapy (CBT) that have proven to be effective in non-cancer contexts often show little or no effects in cancer patients.
“Therapies such as cognitive behavioral therapy (CBT) that have proven to be effective in non-cancer contexts often show little or no effects in cancer patients [76–79].”
The citation lists haven’t been fetched yet
References 153 · Cited by 53
- Authors
- Spiegel, D.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Spiegel, David
- ORCID
- Spiegel, David
- Venue
- British Journal of Health Psychology
- Publisher
- Wiley
- Published
- 2013-08-26
- Volume
- 19
- Issue
- 3
- Pages
- 465-485
- ISSN
- 1359-107X (ISSN-L)
- 2044-8287
- OpenAlex
- W2096178281
- Cited by
- 53
- References
- 153
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 14 · 2016: 10 · 2014: 3 · 2013: 1
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- British Journal of Health Psychology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA118567)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- psychotherapy, cancer survival, depression, breast cancer, psychosocial support, stress, cortisol, inflammation, telomeres, telomerase, natural killer cells, p53, BRCA1, sympathetic nervous system, vascular endothelial growth factor, tumor progression, quality of life
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplasms, Psychotherapy, Social Support, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review